REBECCA CEBULL: Open Payments
NPI 1609345529 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,611 in 25 payments from 6 companies in 2025. Trend: 2023 $910 · 2024 $1,147 · 2025 $2,611
Consulting: $1,230Food & beverage: $974Travel & lodging: $407
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 4 | $1,550 |
| Genentech, Inc. | 4 | $289 |
| Biogen, Inc. | 5 | $288 |
| Novartis Pharmaceuticals Corporation | 7 | $275 |
| GENZYME CORPORATION | 4 | $183 |
| Celgene Corporation | 1 | $27 |
Products named: BRIUMVI, KESIMPTA, TYSABRI, Ocrevus, Ocrevus Zunovo, ZEPOSIA, VUMERITY.
Industry payments across OH — which companies pay providers there.
